Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBDC Barings BDC	$8.86 +0.3%	$9.33	$7.66 ▼ $10.85	$933.50M	0.56	451,754 shs	303,395 shs
BCSF Bain Capital Specialty Finance	$15.53 +0.6%	$16.40	$13.20 ▼ $19.21	$1.00B	0.79	245,958 shs	149,739 shs
HQH Abrdn Healthcare Investors	$15.97 -1.0%	$16.17	$13.77 ▼ $19.79	$859.91M	0.83	184,628 shs	125,134 shs
TPVG TriplePoint Venture Growth BDC	$6.20 +0.4%	$6.93	$5.53 ▼ $9.70	$249.01M	1.65	388,561 shs	187,234 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBDC Barings BDC	+0.29%	+2.09%	-7.89%	-10.50%	-4.26%
BCSF Bain Capital Specialty Finance	+0.78%	+3.81%	-7.57%	-12.60%	-4.81%
HQH Abrdn Healthcare Investors	-0.96%	+5.80%	-3.65%	-10.06%	-1.02%
TPVG TriplePoint Venture Growth BDC	+0.39%	+3.83%	-13.28%	-21.07%	-34.90%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBDC Barings BDC	1.4955 of 5 stars	1.0	3.0	1.7	0.0	3.2	0.8	1.9
BCSF Bain Capital Specialty Finance	2.9496 of 5 stars	2.3	5.0	1.7	0.0	3.0	1.7	1.3
HQH Abrdn Healthcare Investors	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TPVG TriplePoint Venture Growth BDC	1.806 of 5 stars	2.9	2.0	1.7	0.0	2.9	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBDC Barings BDC	2.00	Hold	$9.50	7.27% Upside
BCSF Bain Capital Specialty Finance	2.50	Moderate Buy	$18.00	15.90% Upside
HQH Abrdn Healthcare Investors	0.00	N/A	N/A	N/A
TPVG TriplePoint Venture Growth BDC	1.83	Reduce	$6.96	12.16% Upside

Current Analyst Ratings Breakdown

Latest TPVG, BBDC, BCSF, and HQH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/17/2025	TPVG TriplePoint Venture Growth BDC	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$7.50 ➝ $6.00
4/8/2025	BBDC Barings BDC	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$10.50 ➝ $9.50
4/8/2025	BCSF Bain Capital Specialty Finance	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$18.00 ➝ $17.00
4/8/2025	TPVG TriplePoint Venture Growth BDC	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$7.50 ➝ $7.00
4/8/2025	TPVG TriplePoint Venture Growth BDC	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.00 ➝ $7.00
3/18/2025	TPVG TriplePoint Venture Growth BDC	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.00 ➝ $7.25
3/17/2025	TPVG TriplePoint Venture Growth BDC	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$7.50 ➝ $6.50
3/6/2025	TPVG TriplePoint Venture Growth BDC	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$7.50 ➝ $8.00
3/4/2025	BCSF Bain Capital Specialty Finance	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Perform ➝ Market Perform	$17.00 ➝ $18.00
3/3/2025	BCSF Bain Capital Specialty Finance	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$18.00 ➝ $19.00
1/29/2025	BCSF Bain Capital Specialty Finance	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$17.00 ➝ $18.00

(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBDC Barings BDC	$123.59M	7.55	$0.96 per share	9.24	$11.28 per share	0.79
BCSF Bain Capital Specialty Finance	$138.19M	7.26	N/A	N/A	N/A	∞
HQH Abrdn Healthcare Investors	$186.46M	4.61	N/A	N/A	N/A	∞
TPVG TriplePoint Venture Growth BDC	$45.53M	5.47	$1.56 per share	3.98	$9.60 per share	0.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBDC Barings BDC	$110.29M	$1.04	8.52	∞	N/A	38.54%	10.94%	4.95%	5/8/2025 (Confirmed)
BCSF Bain Capital Specialty Finance	$123.38M	$1.85	7.80	8.30	N/A	43.62%	11.90%	5.43%	5/5/2025 (Estimated)
HQH Abrdn Healthcare Investors	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TPVG TriplePoint Venture Growth BDC	-$39.82M	$0.82	29.54	4.85	N/A	9.01%	16.86%	7.15%	4/29/2025 (Estimated)

Latest TPVG, BBDC, BCSF, and HQH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	BBDC Barings BDC	$0.28	N/A	N/A	N/A	$67.78 million	N/A
5/7/2025	Q1 2025	TPVG TriplePoint Venture Growth BDC	$0.30	N/A	N/A	N/A	$24.90 million	N/A
5/5/2025	Q1 2025	BCSF Bain Capital Specialty Finance	$0.48	N/A	N/A	N/A	$71.00 million	N/A
3/5/2025	Q4 2024	TPVG TriplePoint Venture Growth BDC	$0.35	$0.32	-$0.03	-$0.18	$26.68 million	$25.75 million
2/27/2025	Q4 2024	BCSF Bain Capital Specialty Finance	$0.49	$0.52	+$0.03	$0.34	$67.50 million	$73.30 million
2/20/2025	Q4 2024	BBDC Barings BDC	$0.29	$0.28	-$0.01	$0.24	$69.35 million	$70.63 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBDC Barings BDC	$1.04	11.74%	+9.37%	100.00%	N/A
BCSF Bain Capital Specialty Finance	$1.68	10.82%	+7.30%	90.81%	N/A
HQH Abrdn Healthcare Investors	$2.37	14.84%	+101.58%	N/A	N/A
TPVG TriplePoint Venture Growth BDC	$1.20	19.34%	+0.48%	146.34%	N/A

Latest TPVG, BBDC, BCSF, and HQH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/4/2025	BCSF Bain Capital Specialty Finance	quarterly	$0.03	9%	12/16/2025	12/16/2025	12/30/2025
3/3/2025	BCSF Bain Capital Specialty Finance	quarterly	$0.03	9%	12/16/2025	12/16/2025	12/30/2025
2/27/2025	BCSF Bain Capital Specialty Finance	--	$0.45	8.8%	3/17/2025	3/17/2025	3/31/2025
2/11/2025	HQH Abrdn Healthcare Investors	quarterly	$0.57	13%	2/21/2025	2/21/2025	3/31/2025
3/5/2025	TPVG TriplePoint Venture Growth BDC	quarterly	$0.30	16.4%	3/17/2025	3/17/2025	3/31/2025
2/20/2025	BBDC Barings BDC	quarterly	$0.26	9.89%	3/5/2025	3/5/2025	3/12/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBDC Barings BDC	0.37	0.14	0.14
BCSF Bain Capital Specialty Finance	1.13	1.41	1.41
HQH Abrdn Healthcare Investors	N/A	N/A	N/A
TPVG TriplePoint Venture Growth BDC	N/A	0.14	0.14

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBDC Barings BDC	44.09%
BCSF Bain Capital Specialty Finance	N/A
HQH Abrdn Healthcare Investors	32.60%
TPVG TriplePoint Venture Growth BDC	12.77%

Insider Ownership

Company	Insider Ownership
BBDC Barings BDC	0.52%
BCSF Bain Capital Specialty Finance	0.59%
HQH Abrdn Healthcare Investors	7.30%
TPVG TriplePoint Venture Growth BDC	1.46%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBDC Barings BDC	26	105.41 million	104.94 million	Optionable
BCSF Bain Capital Specialty Finance	1,000	64.62 million	64.18 million	Optionable
HQH Abrdn Healthcare Investors	147,000	53.86 million	46.93 million	Not Optionable
TPVG TriplePoint Venture Growth BDC	N/A	40.14 million	40.05 million	Optionable

TPVG, BBDC, BCSF, and HQH Headlines

Recent News About These Companies

Alpine Global Management LLC Takes Position in TriplePoint Venture Growth BDC Corp. (NYSE:TPVG)

April 24 at 7:16 AM | marketbeat.com

TriplePoint Venture Growth BDC Corp. to Announce 2025 First Quarter Financial Results on ...

April 23 at 4:54 PM | gurufocus.com

UBS Group Lowers TriplePoint Venture Growth BDC (NYSE:TPVG) Price Target to $6.00

April 20, 2025 | americanbankingnews.com

TriplePoint Venture price target lowered to $6 from $7.50 at UBS

April 18, 2025 | markets.businessinsider.com

TriplePoint Venture Gwth Stock Short Interest Report | NYSE:TPVG | Benzinga

April 18, 2025 | benzinga.com

Trexquant Investment LP Grows Position in TriplePoint Venture Growth BDC Corp. (NYSE:TPVG)

April 12, 2025 | marketbeat.com

TriplePoint Venture Growth (TPVG) Receives a Hold from Piper Sandler

April 10, 2025 | theglobeandmail.com

Keefe, Bruyette & Woods Issues Pessimistic Forecast for TriplePoint Venture Growth BDC (NYSE:TPVG) Stock Price

April 10, 2025 | marketbeat.com

Piper Sandler Lowers TriplePoint Venture Growth BDC (NYSE:TPVG) Price Target to $7.00

April 10, 2025 | marketbeat.com

TriplePoint Venture price target lowered to $7 from $8 at Piper Sandler

April 9, 2025 | markets.businessinsider.com

TriplePoint Venture price target lowered to $7 from $7.50 at Keefe Bruyette

April 9, 2025 | markets.businessinsider.com

I'm Collecting A 17% Yield By Holding TriplePoint Venture

March 20, 2025 | seekingalpha.com

TriplePoint Venture price target lowered to $7.25 from $8 at Compass Point

March 18, 2025 | markets.businessinsider.com

Compass Point Sticks to Its Hold Rating for TriplePoint Venture Growth (TPVG)

March 18, 2025 | markets.businessinsider.com

Wells downgrades TriplePoint to Underweight on credit risk

March 17, 2025 | markets.businessinsider.com

TriplePoint Venture downgraded to Underweight from Equal Weight at Wells Fargo

March 17, 2025 | markets.businessinsider.com

TriplePoint Venture Growth: The Tide Hasn't Turned Yet

March 10, 2025 | seekingalpha.com

TriplePoint Venture Growth: When One Dividend Cut Is Not Enough

March 8, 2025 | seekingalpha.com

TriplePoint Venture Growth BDC Corp. (NYSE:TPVG) Q4 2024 Earnings Call Transcript

March 6, 2025 | msn.com

Q4 2024 Triplepoint Venture Growth BDC Corp Earnings Call

March 6, 2025 | uk.finance.yahoo.com

Wells Fargo Remains a Hold on TriplePoint Venture Growth (TPVG)

March 6, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TPVG, BBDC, BCSF, and HQH Company Descriptions

Barings BDC NYSE:BBDC

$8.86 +0.03 (+0.29%)

Closing price 04/25/2025 03:59 PM Eastern

Extended Trading

$8.92 +0.07 (+0.77%)

As of 04/25/2025 05:31 PM Eastern

Barings BDC, Inc. is a publicly traded, externally managed investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. It seeks to invest primarily in senior secured loans, first lien debt, unitranche, second lien debt, subordinated debt, equity co-investments and senior secured private debt investments in private middle-market companies that operate across a wide range of industries. It specializes in mezzanine, leveraged buyouts, management buyouts, ESOPs, change of control transactions, acquisition financings, growth financing, and recapitalizations in lower middle market, mature, and later stage companies. It invests in manufacturing and distribution; business services and technology; transportation and logistics; consumer product and services. It invests in United States. It invests in companies with EBITDA of $10 million to $75 million, typically in private equity sponsor backed.

Bain Capital Specialty Finance NYSE:BCSF

$15.53 +0.09 (+0.58%)

Closing price 04/25/2025 03:59 PM Eastern

Extended Trading

$15.53 0.00 (0.00%)

As of 04/25/2025 04:20 PM Eastern

Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.

Abrdn Healthcare Investors NYSE:HQH

$15.96 -0.17 (-1.02%)

Closing price 04/25/2025 03:59 PM Eastern

Extended Trading

$15.98 +0.02 (+0.09%)

As of 04/25/2025 04:05 PM Eastern

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

TriplePoint Venture Growth BDC NYSE:TPVG

$6.20 +0.02 (+0.39%)

Closing price 04/25/2025 03:58 PM Eastern

Extended Trading

$6.22 +0.01 (+0.18%)

As of 04/25/2025 07:18 PM Eastern

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time